Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$81.11

0.11 (0.14%)

06:48
10/05/16
10/05
06:48
10/05/16
06:48

Elanco to acquire U.S. feline, canine, rabies vaccines portfolio for $885M

Elanco U.S., Inc., a subsidiary of Eli Lilly (LLY), announced an agreement to acquire Boehringer Ingelheim Vetmedica, Inc.'s, or BIVI, U.S. feline, canine and rabies vaccines portfolio - as well as a fully integrated manufacturing and R&D site - for $885M, including the estimated cost of acquired inventory. The deal will diversify Elanco's U.S. companion animal portfolio by complementing its offerings for dogs and cats. The Fort Dodge, Iowa-based facility brings capacity to manufacture the acquired products as well as R&D and testing capabilities, including an on-site veterinary research center and lab space. The acquisition is anticipated to close by early 2017, subject to approval by the Federal Trade Commission and also subject to antitrust approval and closing of Boehringer Ingelheim's asset swap transaction with Sanofi (SNY).

  • 07

    Oct

  • 25

    Oct

  • 06

    Nov

LLY Eli Lilly
$81.11

0.11 (0.14%)

09/28/16
BERN
09/28/16
NO CHANGE
BERN
Biogen likely to benefit from Lilly Alzheimer's drug results, says Bernstein
Bernstein analyst Aaron Gal says that the results of a trial of Eli Lilly's (LLY) Alzheimer's drug, solanezumab, due out in late 2016 or early 2017, are likely to impact perceptions of Biogen's (BIIB) Alzheimer's drug, aducanumab. The analyst expects Lilly's solanezumab "to show at least directional evidence" of cognitive improvement, although he is "less convinced" that the impact will be clearly statistically significant. The best results from Biogen's perspective will be if Lilly's drug shows "marginal success," according to Gal. However, statistically significant results are also good for Biogen, as they will show that reducing amyloid beta does mitigate Alzheimer's symptoms, the analyst stated. And if Lilly's drug completely fails, Biogen's drug "could well succeed," given the significant differences between them, wrote Gal,who gives Biogen's aducanumab a 65% chance of success. He keeps a $345 price target and Outperform rating on Biogen.
09/27/16
09/27/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Eli Lilly (LLY) upgraded to Buy from Neutral at Goldman with analyst Jami Rubin saying the company is entering a long lasting period of accelerating topline and earnings growth driven by its late stage pipeline. 2. AutoZone (AZO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman saying the company is at a positive inflection in 7 year and older vehicles, which is strongly correlated to same-store-sales. 3. Consolidated Edison (ED) upgraded to Hold from Sell at Evercore ISI with analyst Greg Gordon saying the joint settlement proposal filed in the CECONY rate case mitigates downside risk. 4. Crown Holdings (CCK) upgraded on multiple catalysts at BMO Capital with analyst Mark Wilde citing valuation, his belief that the company will resume returning cash to shareholders in 2017, and his belief that the company's results should be boosted by " a wave of domestic and offshore expansion projects." 5. Francesca's (FRAN) upgraded to Buy from Hold at Stifel with analyst Richard Jaffe saying the company's "appealing merchandise" makes it very likely that its sales will grow going forward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/27/16
GSCO
09/27/16
UPGRADE
Target $95
GSCO
Buy
Eli Lilly upgraded to Buy from Neutral at Goldman
Goldman analyst Jami Rubin upgraded Eli Lilly to Buy and increased its price target to $95 from $89 saying the company is entering a long lasting period of accelerating topline and earnings growth driven by its late stage pipeline. Rubin projects $12.5B of new product sales by 2020 and double digit earnings growth over the next five years, even without Sola. The analyst sees a 35%, up from 25%, probability of success for Sola with a bull case scenario that can lead to almost $7.5B in peak sales and "super charge" earnings. Even without Sola, Rubin sees favorable risk/reward given durability of earnings and said it is the least exposed to above-CPI price increases.
09/21/16
JANY
09/21/16
DOWNGRADE
Target $36
JANY
Neutral
Janney downgrades Clovis with buyout speculation at 'fever pitch'
Janney Capital analyst Roy Buchanan downgraded Clovis Oncology (CLVS) to Neutral from Buy with an increased fair value estimate of $36. Clovis is up 17c to $35.00 in late morning trading. In a research note partially titled, "May Be Right, May Be Crazy - M&A Speculation At Fever Pitch," Buchanan says there is a "finite chance" that Clovis will need to market its PARP inhibitor rucaparib by itself. He believes a late-2016 approval for rucaparib is likely. The analyst attributes his increased fair value estimate to "acquisition optionality." Reports of Takeda's (TKPYY) reserving up to $15B for acquisitions and Medivation's (MDVN) takeout have given Clovis shares a lift, Buchanan tells investors. The analyst adds that rumors surfaced yesterday of potential interest in the company from Eli Lilly (LLY).

TODAY'S FREE FLY STORIES

RTIX

RTI Surgical

$3.20

-0.1 (-3.03%)

09:03
12/08/16
12/08
09:03
12/08/16
09:03
Hot Stocks
RTI Surgical says its C-Plus Peek IBF System now indicated for allograft use »

RTI Surgical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDSY

I.D. Systems

$4.70

-0.24 (-4.86%)

09:03
12/08/16
12/08
09:03
12/08/16
09:03
Hot Stocks
I.D. Systems appoints Chris Wolfe as CEO »

I.D. Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:02
12/08/16
12/08
09:02
12/08/16
09:02
Conference/Events
House Financial Services Committee to hold a hearing »

The Capital Markets &…

DL

China Distance Education

$12.34

0.62 (5.29%)

09:02
12/08/16
12/08
09:02
12/08/16
09:02
Hot Stocks
China Distance Education revises share issuance plan on China's New Third Board »

China Distance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$74.67

0.81 (1.10%)

09:01
12/08/16
12/08
09:01
12/08/16
09:01
Hot Stocks
Duke Energy Renewables acquires Colorado solar project »

Duke Energy Renewables…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMI

Valmont

$154.30

4.45 (2.97%)

08:59
12/08/16
12/08
08:59
12/08/16
08:59
Recommendations
Valmont analyst commentary  »

Valmont facing multiple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

REXR

Rexford Industrial

$22.41

0.41 (1.86%)

08:57
12/08/16
12/08
08:57
12/08/16
08:57
Hot Stocks
Rexford Industrial acquires industrial property for $24.4M, sells two for $19M »

Rexford Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

lululemon

$59.84

2.6 (4.54%)

, HZNP

Horizon Pharma

$19.39

-0.82 (-4.06%)

08:56
12/08/16
12/08
08:56
12/08/16
08:56
Hot Stocks
On The Fly: Pre-market Movers »

UP AFTER EARNINGS:…

LULU

lululemon

$59.84

2.6 (4.54%)

HZNP

Horizon Pharma

$19.39

-0.82 (-4.06%)

AMD

AMD

$9.56

0.11 (1.16%)

TLRD

Tailored Brands

$18.93

0.62 (3.39%)

CTRV

ContraVir Pharmaceuticals

$1.99

-0.01 (-0.50%)

AVXL

Anavex

$3.73

-0.1 (-2.61%)

HRB

H&R Block

$23.34

0.65 (2.86%)

VYGR

Voyager Therapeutics

$13.73

-0.27 (-1.93%)

CMTL

Comtech

$12.75

0.77 (6.43%)

VRNT

Verint

$38.30

0.1 (0.26%)

VNCE

Vince Holding

$4.55

0.35 (8.33%)

CASY

Casey's General Stores

$124.22

1.14 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 14

    Dec

  • 09

    Jan

F

Ford

$13.06

0.5 (3.98%)

, BAC

Bank of America

$22.57

0.41 (1.85%)

08:55
12/08/16
12/08
08:55
12/08/16
08:55
Options
Notable open interest changes for December 8th »

Wednesday's total…

F

Ford

$13.06

0.5 (3.98%)

BAC

Bank of America

$22.57

0.41 (1.85%)

AAPL

Apple

$111.03

1.08 (0.98%)

WFC

Wells Fargo

$57.28

1.73 (3.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 05

    Jan

  • 10

    Jan

  • 13

    Jan

  • 13

    Mar

08:55
12/08/16
12/08
08:55
12/08/16
08:55
General news
FX Action: The dollar »

FX Action: The dollar…

BHI

Baker Hughes

$66.14

-0.75 (-1.12%)

08:55
12/08/16
12/08
08:55
12/08/16
08:55
Conference/Events
Baker Hughes to hold an investor meeting »

Investor Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

CIEN

Ciena

$21.60

0.6 (2.86%)

08:54
12/08/16
12/08
08:54
12/08/16
08:54
Hot Stocks
Ciena sees Q1 adjusted gross margin in mid-40's percentage range »

Sees Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

CIEN

Ciena

$21.60

0.6 (2.86%)

08:51
12/08/16
12/08
08:51
12/08/16
08:51
Hot Stocks
Ciena sees FY17 revenue growth faster than the market »

FY17 consensus $2.8B.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AAPL

Apple

$111.03

1.08 (0.98%)

08:50
12/08/16
12/08
08:50
12/08/16
08:50
Periodicals
Apple, Goldwind partner to supply clean energy in China, SCMP reports »

Wind power turbine maker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

08:50
12/08/16
12/08
08:50
12/08/16
08:50
General news
The 10k initial claims drop to 258k »

The 10k initial claims…

DRAM

Dataram

$1.27

0.07 (5.83%)

08:48
12/08/16
12/08
08:48
12/08/16
08:48
Hot Stocks
Dataram acquisition targt U.S. Gold Corp. expands claims in Nevada »

Dataram's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCAP

Jernigan Capital

$20.21

-0.05 (-0.25%)

08:48
12/08/16
12/08
08:48
12/08/16
08:48
Syndicate
Jernigan Capital 2.65M share Spot Secondary priced at $19.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

$DJT

DJ Transportation Average

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHIP

Seanergy Marine

$2.20

-0.1 (-4.35%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Syndicate
Seanergy Marine raises $15M in common stock and warrant offering »

Seanergy Marine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDUS

Radius Health

$53.50

-1.51 (-2.75%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Hot Stocks
Radius Health presents RAD1901 Phase 1 data at SABCS »

Radius Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

DJX

Dow Jones Industrial Average

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$168.84

4.1 (2.49%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$48.18

0.9 (1.90%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$75.95

0.6 (0.80%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.